Patent ID: 7704498
Filing Date: 2010-04-27
Classification: A61K,A61P,C07K,G01N

Abstract:
1. A composition comprising an effective amount of an antagonist of a human ErbB4 receptor, in admixture with a pharmaceutically acceptable carrier, wherein said antagonist is selected from the group consisting of an antibody produced by a hybridoma selected from the group consisting of HER4.10H1.1A1 (ATCC Accession Number PTA-2828), HER4.1C6.A1 (ATCC Accession Number PTA-2829), HER4.3B9.2C9 (ATCC Accession Number PTA-2826), HER4.1A6.5B3 (ATCC Accession Number PTA-2827) and HER4.8B1.2H2 (ATCC Accession Number PTA-2825) and an antigen binding fragment thereof.